- Home
- ACLX vs INTA Comparison
ACLX vs INTA Comparison
Compare ACLX & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- INTA
- Stock Information
- Founded
- ACLX 2015
- INTA 2000
- Country
- ACLX United States
- INTA United States
- Employees
- ACLX N/A
- INTA N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- INTA Computer Software: Prepackaged Software
- Sector
- ACLX Health Care
- INTA Technology
- Exchange
- ACLX Nasdaq
- INTA Nasdaq
- Market Cap
- ACLX 4.1B
- INTA 3.4B
- IPO Year
- ACLX 2022
- INTA 2021
- Fundamental
- Price
- ACLX $76.42
- INTA $44.92
- Analyst Decision
- ACLX Strong Buy
- INTA Buy
- Analyst Count
- ACLX 13
- INTA 9
- Target Price
- ACLX $114.75
- INTA $62.50
- AVG Volume (30 Days)
- ACLX 507.4K
- INTA 880.7K
- Earning Date
- ACLX 11-06-2025
- INTA 11-03-2025
- Dividend Yield
- ACLX N/A
- INTA N/A
- EPS Growth
- ACLX N/A
- INTA N/A
- EPS
- ACLX N/A
- INTA N/A
- Revenue
- ACLX $56,979,000.00
- INTA $504,120,000.00
- Revenue This Year
- ACLX N/A
- INTA $15.18
- Revenue Next Year
- ACLX $174.18
- INTA $13.51
- P/E Ratio
- ACLX N/A
- INTA N/A
- Revenue Growth
- ACLX N/A
- INTA 17.09
- 52 Week Low
- ACLX $47.86
- INTA $35.51
- 52 Week High
- ACLX $107.37
- INTA $77.74
- Technical
- Relative Strength Index (RSI)
- ACLX 61.10
- INTA 53.78
- Support Level
- ACLX $73.16
- INTA $43.26
- Resistance Level
- ACLX $78.61
- INTA $46.83
- Average True Range (ATR)
- ACLX 2.84
- INTA 1.46
- MACD
- ACLX 0.55
- INTA -0.04
- Stochastic Oscillator
- ACLX 75.42
- INTA 36.07
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.